Sygnature Discovery Strengthens Management Team
Colin Sambrook Smith Appointed as Head of Computational Chemistry and Informatics
Sygnature Discovery Limited announced the appointment of Colin Sambrook Smith to the newly-created role of Head of Computational Chemistry and Informatics.
Colin Sambrook Smith
Simon Hirst, Sygnature’s Chief Executive Officer stated, “I am delighted to welcome Colin to Sygnature Discovery. He is a great addition to our management team. Colin is an experienced computational chemist and research manager with a proven ability to analyse and determine the scientific computing and information technology needs of research-based organisations. He has 26 years of R&D experience mostly within the pharmaceutical industry. Colin’s most recent role was at OSI Prosidion as Director of Research Technologies, where he was responsible for informatics, computational chemistry, array chemistry and analytical chemistry. He was also a member of the Research Steering Group which set and reviewed all research priorities and goals for Prosidion. Colin is already contributing his expertise into several on-going projects and is managing a new, fully-integrated drug discovery programme for a European biotech company.”
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
